Advertisement
Canada markets closed

  • S&P/TSX

    21,807.37
    +98.93 (+0.46%)
     

  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     

  • DOW

    37,986.40
    +211.02 (+0.56%)
     

  • CAD/USD

    0.7275
    +0.0012 (+0.16%)
     

  • CRUDE OIL

    83.24
    +0.51 (+0.62%)
     

  • Bitcoin CAD

    88,065.46
    +774.09 (+0.89%)
     

  • CMC Crypto 200

    1,369.05
    +56.43 (+4.30%)
     

  • GOLD FUTURES

    2,406.70
    +8.70 (+0.36%)
     

  • RUSSELL 2000

    1,947.66
    +4.70 (+0.24%)
     

  • 10-Yr Bond

    4.6150
    -0.0320 (-0.69%)
     

  • NASDAQ

    15,282.01
    -319.49 (-2.05%)
     

  • VOLATILITY

    18.71
    +0.71 (+3.94%)
     

  • FTSE

    7,895.85
    +18.80 (+0.24%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • CAD/EUR

    0.6824
    +0.0003 (+0.04%)
     

Free Stock Performance Review on ViewRay and Three Additional Medical Equipment Stocks

ACCESSWIRE

Stock Research Monitor: WMGI, ZBH, and ARAY

LONDON, UK / ACCESSWIRE / July 17, 2018 / If you want a free Stock Review on VRAY sign up now at www.wallstequities.com/registration. Pre-market today, WallStEquities.com presents the following Medical Appliances and Equipment stocks for review: ViewRay Inc. (NASDAQ: VRAY), Wright Medical Group N.V. (NASDAQ: WMGI), Zimmer Biomet Holdings Inc. (NYSE: ZBH), and Accuray Inc. (NASDAQ: ARAY). These equities also belong to the Healthcare sector, which is made up of companies that specialize in products and services related to health and medical care. All you have to do is sign up today for this free limited time offer by clicking the link below.

www.wallstequities.com/registration

ViewRay

Oakwood Village, Ohio headquartered ViewRay Inc.'s stock finished Monday's session 0.45% higher at $8.97 with a total trading volume of 533,840 shares. Over the last month and the previous three months, the Company's shares have advanced 18.81% and 26.61%, respectively. Additionally, the stock has gained 38.21% over the past year. Shares of the Company are trading above their 50-day and 200-day moving averages by 19.89% and 14.37%, respectively. Moreover, shares of ViewRay, which through its subsidiary, ViewRay Technologies, Inc., designs, manufactures, and markets radiation therapy systems, have a Relative Strength Index (RSI) of 74.24.

ADVERTISEMENT

On July 03rd, 2018, research firm Jefferies initiated a 'Buy' rating on the Company's stock.

On July 11th, 2018, ViewRay announced that its MRIdian® Linac has been selected for installation at Centre Georges-François Leclerc in Dijon, France as part of a tender award contract with UNICANCER, a hospital network of 19 French Comprehensive Cancer Centers. MRIdian Linac combines the latest innovations in precision radiation delivery with ground-breaking MR image guidance. Get the full research report on VRAY for free by clicking below at:

www.wallstequities.com/registration/?symbol=VRAY

Wright Medical Group

Shares in Amsterdam, the Netherlands headquartered Wright Medical Group N.V. rose slightly by 0.04%, ending yesterday's session at $25.49 with a total trading volume of 946,719 shares. The stock has gained 23.74% in the previous three months. The Company's shares are trading 2.79% above their 50-day moving average and 9.99% above their 200-day moving average. Moreover, shares of the Company, which designs, manufactures, markets, and sells extremities and biologics products, have an RSI of 48.11.

On June 11th, 2018, Wright Medical announced that the operating results for its Q2 ended July 01st, 2018, will be released at 3:05 p.m. CT on August 08th, 2018. The Company will host a conference call at 3:30 p.m. CT that same day to discuss its results. A simultaneous webcast of the call will be available on the Company's corporate website. Find your free research report on WMGI at:

www.wallstequities.com/registration/?symbol=WMGI

Zimmer Biomet Holdings

On Monday, Warsaw, Indiana headquartered Zimmer Biomet Holdings Inc.'s stock dropped 1.97%, to close the day at $112.63. A total volume of 716,525 shares was traded. The Company's shares have advanced 5.03% in the previous three months. The stock is trading 0.71% below its 50-day moving average. Additionally, shares of Zimmer Biomet, which together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, EMEA region, and Asia/Pacific, have an RSI of 47.00.

On June 20th, 2018, Zimmer Biomet announced that it will issue a news release detailing the Company's Q2 results at 6:00 a.m. ET on July 27th, 2018. The Company will host its sales and earnings conference call at 8:30 a.m. ET that same day. The audio webcast of the call can be accessed on the Company's Investor Relations website.

On June 27th, 2018, research firm Bernstein initiated an 'Underperform' rating on the Company's stock, with a target price of $96 per share. Sign up today for the free research report on ZBH at:

www.wallstequities.com/registration/?symbol=ZBH

Accuray

Shares in Sunnyvale, California headquartered Accuray Inc. ended the day 1.28% lower at $3.85. A total volume of 178,980 shares was traded. The stock is trading below its 50-day moving average by 12.77%. Furthermore, shares of Accuray, which designs, develops, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body, have an RSI of 36.38.

On June 21st, 2018, Accuray announced that it has received an Atomic Energy Regulatory Board (AERB) Type Approval for its Radixact® X9 System in India. The AERB Type Approval indicates the device conforms to established safety standards and will enable the Company to sell, and Indian hospitals throughout the country to import, this next-generation TomoTherapy® platform. Wall St. Equities' research coverage also includes the downloadable free report on ARAY at:

www.wallstequities.com/registration/?symbol=ARAY

Wall St. Equities:

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

WSE has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@wallstequities.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

https://wallstequities.com/legal-disclaimer/

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@wallstequities.com

Phone number: 21 32 044 483

Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Wall St. Equities